Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

A session filmed at the 64th ASH Annual Meeting and Exposition congress, featuring experts Matthew Davids and Lindsey Roeker, who share their highlights in CLL, including the role of doublet therapies and clinical trial updates.

 

Welcome to The CLL Sessions brought to you by the Video Journal of Hematological Oncology (VJHemOnc). This exclusive session features a roundtable discussion from the 64th ASH Annual Meeting and Exposition congress, with leading experts Matthew Davids, MD, Dana-Farber Cancer Institute, Boston, MA, and Lindsey Roeker, MD, Memorial Sloan Kettering Cancer Center, New York, NY, who share key updates in chronic lymphocytic leukemia (CLL). The experts discuss several topics, including the role of doublet therapies, long-term follow-up data from clinical trials, and further highlight the impact of novel Bruton’s tyrosine kinase (BTK) inhibitors in the field.

Watch all videos from ASH 2022
Listen to the podcast

The CLL Channel on VJHemOnc is supported by Janssen Pharmaceuticals (a Johnson & Johnson Company).

This supporter has no influence over the production of the content.

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals